Tenax Therapeutics (TENX) News Today $5.86 +0.02 (+0.26%) As of 12:04 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TENX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Tenax Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate UpdateMay 14, 2025 | globenewswire.comTenax Therapeutics Inc.May 9, 2025 | barrons.comTenax: Phase 3 Heart Failure Program Continues With 2 Key CatalystsApril 16, 2025 | seekingalpha.comTenax Therapeutics files to sell 4.14M shares of common stock for holdersApril 16, 2025 | markets.businessinsider.comTenax Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare ConferenceMarch 31, 2025 | globenewswire.comTenax Therapeutics reports Q4 EPS (18c), consensus (43c)March 27, 2025 | markets.businessinsider.comTenax Therapeutics (TENX) Gets a Buy from William BlairMarch 27, 2025 | markets.businessinsider.comTenax Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate UpdateMarch 25, 2025 | globenewswire.comTenax Therapeutics Inc TENXMarch 15, 2025 | morningstar.comRoth MKM Reaffirms Their Buy Rating on Tenax Therapeutics (TENX)March 6, 2025 | markets.businessinsider.comTenax Therapeutics expands Phase 3 LEVEL program for TNX-103March 5, 2025 | markets.businessinsider.comTenax Therapeutics prices 378,346 shares at $6.04 in private placementMarch 5, 2025 | markets.businessinsider.comTenax Therapeutics Announces $25 Million Private PlacementMarch 5, 2025 | globenewswire.comTenax Therapeutics Expands Phase 3 LEVEL Program, Advancing Two TNX-103 (Oral Levosimendan) Registrational Studies for the Treatment of PH-HFpEFMarch 5, 2025 | globenewswire.comTenax Therapeutics to Participate in the Leerink Partners 2025 Global Healthcare ConferenceMarch 3, 2025 | markets.businessinsider.comTenax Therapeutics to Participate in the Guggenheim SMID Cap Biotech ConferenceJanuary 31, 2025 | globenewswire.comTenax Therapeutics, Inc. Common Stock (TENX) Insider ActivityJanuary 28, 2025 | nasdaq.comTenax Therapeutics Appoints Gillian Andor Vice President, Clinical OperationsJanuary 22, 2025 | markets.businessinsider.comWill Tenax Therapeutics (NASDAQ:TENX) Spend Its Cash Wisely?December 6, 2024 | finance.yahoo.comTenax Therapeutics Appoints Interim CFO Thomas McGauleyDecember 4, 2024 | tipranks.comTenax Therapeutics, Inc. (TENX) Guggenheim Healthcare Innovation Conference (Transcript)November 15, 2024 | seekingalpha.comTenax Therapeutics reports Q3 EPS 19c, consensus ($1.39)November 14, 2024 | markets.businessinsider.comTenax Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate UpdateNovember 13, 2024 | globenewswire.comTenax Therapeutics Expands Stock Incentive PlanOctober 31, 2024 | markets.businessinsider.comTenax Therapeutics to Present at the Guggenheim Healthcare Innovation ConferenceOctober 31, 2024 | globenewswire.comTenax Therapeutics initiated with an Outperform at LeerinkOctober 25, 2024 | markets.businessinsider.comLeerink Partners Initiates Coverage of Tenax Therapeutics (TENX) with Outperform RecommendationOctober 25, 2024 | msn.comGuggenheim Initiates Coverage of Tenax Therapeutics (TENX) with Buy RecommendationOctober 15, 2024 | msn.comWilliam Blair Initiates Coverage of Tenax Therapeutics (TENX) with Outperform RecommendationOctober 2, 2024 | msn.comTENX: $100 Million Capital RaiseAugust 23, 2024 | finance.yahoo.comTenax Therapeutics, Inc. (TENX)August 15, 2024 | nz.finance.yahoo.comTenax Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate UpdateAugust 14, 2024 | finance.yahoo.comTENX Stock Earnings: Tenax Therapeutics Beats EPS for Q2 2024August 14, 2024 | investorplace.comTenax Therapeutics Announces Closing of $100 Million Private Placement and Plans to Accelerate the Oral Levosimendan Phase 3 ProgramAugust 12, 2024 | finance.yahoo.com3 Penny Stocks to Watch Now, 8/8/24August 8, 2024 | msn.comPound trades at five-week low on dollar, resumes recent slideAugust 7, 2024 | uk.finance.yahoo.comInvestor Sentiment Recovers as Recession Fears Wane, Driving Premarket Gains for US Equity FuturesAugust 7, 2024 | msn.comBiotech Soars Following Oversubscribed $100M Private Placement AnnouncementAugust 6, 2024 | msn.comWhy Is Tenax Therapeutics (TENX) Stock Up 29% Today?August 6, 2024 | investorplace.comTenax Therapeutics Announces Oversubscribed $100 Million Private PlacementAugust 6, 2024 | globenewswire.comTENX: First Quarter ResultsMay 20, 2024 | finance.yahoo.comTenax Therapeutics: Q1 Earnings SnapshotMay 14, 2024 | washingtonpost.comTENX Stock Earnings: Tenax Therapeutics Misses EPS for Q1 2024May 14, 2024 | investorplace.comTenax Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate UpdateMay 14, 2024 | globenewswire.comTenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)April 30, 2024 | globenewswire.comTENX: 2023 Financial ResultsApril 9, 2024 | finance.yahoo.comTenax Therapeutics to Host KOL Event: “LEVEL Setting: the Scientific Rationale for Levosimendan as a Potential First Treatment for PH-HFpEF, and the Ongoing Phase 3 LEVEL Study”April 9, 2024 | globenewswire.comTenax Therapeutics: Q4 Earnings InsightsMarch 28, 2024 | benzinga.comTENX Stock Earnings: Tenax Therapeutics Misses EPS for Q4 2023March 28, 2024 | msn.comTenax Therapeutics Provides Business and Clinical Development Updates with Full Year 2023 Financial ResultsMarch 28, 2024 | globenewswire.com Get Tenax Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TENX and its competitors with MarketBeat's FREE daily newsletter. Email Address TENX Media Mentions By Week TENX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TENX News Sentiment▼1.870.88▲Average Medical News Sentiment TENX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TENX Articles This Week▼10▲TENX Articles Average Week Get Tenax Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TENX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies OptiNose News Entera Bio News Virios Therapeutics News Milestone Pharmaceuticals News Biomea Fusion News Oramed Pharmaceuticals News Vaxart News Climb Bio News Adagene News XBiotech News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TENX) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tenax Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tenax Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TENX Stock Free TENX Stock Alerts